Seminari d'Innovació (VHIR) "Presentation of successful cases in biomedical research entrepreneurship"

 
  Aula 114 del Mòdul Sud, Unitat Docent HUVH —
28/10/2019
28/10/2019 -- From 10:00h to 11:00h
Organize :
Unitat d'Innovació, Vall d'Hebron Institut de Recerca (VHIR)
Modality: In-person
Share it:

Dra. Judit Anido; Vall d'Hebron Institute of Oncology (VHIO) i Dr. Victor Franco Puntes; Principal Investigator of the group Cap CIBBIM-Nanomedicine. Pharmacokinetic Nanoparticles (VHIR)

"Presentation of successful cases in biomedical research entrepreneurship"

The VHIR’s Innovation Unit invites you to share the experience of these two outstanding sicentific entrepreneurs. Dr Anido has led the growth of Mosaic Biomedicals as CEO since its inception in 2012 until its merger with Northern in 2016, and as General Manager afterwards. Dr Puntes is ICREA Research Professor with joint appointments in VHIR and ICN2. He is co-founder of several spin offs, with special emphasis on “Applied Nanoparticles”.

Partipacion does’nt need previous registration, but the room has limited capacity

More information: Innovation -Vall d’Hebron Institute of Research (VHIR) -Tel: (+34) 93 489 40 11
innovacio@vhir.org

 

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.